3,4-methylenedioxyamphetamine has been researched along with fluoxetine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.24) | 18.7374 |
| 1990's | 18 (62.07) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arunotayanun, W; Dalley, JW; Gibbons, S; Huang, XP; Iversen, L; Roth, BL; Setola, V; Treble, R | 1 |
| Callaway, CW; Geyer, MA | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Pan, HS; Wang, RY | 1 |
| Dragunow, M; Laverty, R; Logan, B | 1 |
| Brodkin, J; Nash, JF | 1 |
| Aghajanian, GK; Bradberry, CW; Roth, RH; Sprouse, JS | 2 |
| Callaway, CW; Geyer, MA; Gold, LH; Johnson, MP; Nichols, DE | 1 |
| Azmitia, EC; Murphy, RB; Whitaker-Azmitia, PM | 1 |
| Callaway, CW; Geyer, MA; Wing, LL | 1 |
| Schmidt, CJ; Taylor, VL | 2 |
| Schmidt, CJ | 1 |
| Gibb, JW; Hanson, GR; Johnson, M | 1 |
| Gudelsky, GA; Meltzer, HY; Nash, JF | 1 |
| Harvey, JA; McMaster, SE; Romano, AG | 1 |
| Blyth, AS; Dougall, JR; Kennedy, BW; Nimmo, SM; Tullett, WM | 1 |
| Callaway, CW; Geyer, MA; Rempel, NL | 1 |
| Azmitia, EC; Gu, XF | 1 |
| McCann, UD; Ricaurte, GA | 1 |
| Adler, L; Huether, G; Poeggeler, B; Rüther, E | 1 |
| Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD | 1 |
| Marona-Lewicka, D; Nichols, DE | 1 |
| Connor, TJ; Harkin, A; Kelly, JP; Shanahan, E | 1 |
| Cleary, L; Docherty, JR | 1 |
| Eddington, ND; Upreti, VV | 1 |
| Banas, SM; Belmer, A; Diaz, SL; Doly, S; Fernandez, SP; Guiard, BP; Mameli, M; Maroteaux, L; Moutkine, I; Muzerelle, A; Pitychoutis, PM; Quentin, E; Roumier, A; Tchenio, A | 1 |
| Mansoor, S; Zubair, UB | 1 |
29 other study(ies) available for 3,4-methylenedioxyamphetamine and fluoxetine
| Article | Year |
|---|---|
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Topics: Allyl Compounds; HEK293 Cells; Humans; Indoles; Magnetic Resonance Spectroscopy; Molecular Conformation; Propylamines; Protein Binding; Psychotropic Drugs; Receptors, Serotonin; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Tryptamines | 2013 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cerebral Cortex; Electrophysiology; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Stereoisomerism; Stereotaxic Techniques | 1991 |
3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Basal Ganglia; Caudate Nucleus; Corpus Striatum; Dizocilpine Maleate; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Olfactory Bulb; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Putamen; Rats | 1991 |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluoxetine; Ketanserin; Male; Mazindol; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Sub-picogram determination of serotonin using HPLC with electrochemical detection for microdialysis studies of serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Dialysis; Fluoxetine; Microchemistry; N-Methyl-3,4-methylenedioxyamphetamine; Raphe Nuclei; Rats; Secretory Rate; Serotonin; Tryptophan | 1991 |
Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Amines; Brain Chemistry; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Male; Motor Activity; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cells, Cultured; Embryo, Mammalian; Fluoxetine; Ketanserin; N-Methyl-3,4-methylenedioxyamphetamine; Raphe Nuclei; Rats; Serotonin | 1990 |
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Fluoxetine; Gait; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Fluoxetine; Indenes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1990 |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Cerebral Cortex; Fluoxetine; Hydroxyindoleacetic Acid; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Time Factors | 1987 |
Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analysis of Variance; Animals; Drug Interactions; Fluoxetine; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase; Pargyline; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1989 |
MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Dialysis; Electrophysiology; Fluoxetine; In Vitro Techniques; Male; Mesencephalon; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Passive Cutaneous Anaphylaxis; Raphe Nuclei; Rats; Serotonin; Stereoisomerism; Time Factors | 1989 |
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Ketanserin; Kinetics; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Piperonyl Butoxide; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1987 |
Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Body Temperature; Corticosterone; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1988 |
Methylenedioxyamphetamine: neurotoxic effects on serotonergic projections to brainstem nuclei in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Axonal Transport; Axons; Brain Stem; Designer Drugs; Fluoxetine; Immunohistochemistry; Male; Nerve Fibers; Neurotoxins; Prosencephalon; Rats; Rats, Sprague-Dawley; Serotonin | 1993 |
Drug-induced hyperthermia.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Female; Fluoxetine; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Remoxipride; Thioridazine | 1993 |
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Arousal; Designer Drugs; Dose-Response Relationship, Drug; Drug Interactions; Euphoria; Female; Fluoxetine; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Reinforcement, Psychology; Substance-Related Disorders | 1993 |
Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Fenfluramine; Fluoxetine; Injections, Intraperitoneal; Male; Melatonin; Pargyline; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Receptor Agonists; Tryptophan | 1993 |
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1996 |
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Hallucinogens; Hydroxyindoleacetic Acid; Male; Paroxetine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Serotonin | 2003 |
Actions of amphetamine derivatives and cathinone at the noradrenaline transporter.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Alkaloids; Amphetamines; Animals; Cerebral Cortex; Cocaine; Competitive Bidding; Fluoxetine; In Vitro Techniques; Male; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Wistar; Symporters | 2003 |
Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat.
Topics: 3,4-Methylenedioxyamphetamine; Alcohol Oxidoreductases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Caco-2 Cells; Cytochrome P-450 CYP2D6; Cytochrome P450 Family 2; Drug Interactions; Fluoxetine; Humans; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2008 |
Positive regulation of raphe serotonin neurons by serotonin 2B receptors.
Topics: 3,4-Methylenedioxyamphetamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Amphetamines; Animals; Body Temperature; Central Nervous System Sensitization; Female; Fluoxetine; Indoles; Male; Mice; Mice, Knockout; Mice, Transgenic; Neurogenesis; Prepulse Inhibition; Raphe Nuclei; Receptor, Serotonin, 5-HT2B; Serotonergic Neurons; Serotonin 5-HT2 Receptor Agonists; Thiophenes; Transcription Factors | 2018 |
Erotomania in Depressive Psychosis: Mood Incongruent Delusion in a Depressive Young Woman.
Topics: Bipolar Disorder; Delusions; Depression; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Love; Olanzapine; Psychotic Disorders; Young Adult | 2019 |